LBT Insider Trading

Insider Ownership Percentage: 40.83%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

LBT Innovations Insider Trading History Chart

This chart shows the insider buying and selling history at LBT Innovations by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LBT Innovations Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for LBT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

LBT Innovations Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2023Brenton BarnesInsiderIssued1,031,250A$0.02A$24,750.00
11/15/2023Brenton BarnesInsiderIssued50,000,000A$0.01A$250,000.00
12/29/2021Brian O'DwyerInsiderIssued500,000A$0.07A$36,500.00
See Full Table

SEC Filings (Institutional Ownership Changes) for LBT Innovations (ASX:LBT)

0.26% of LBT Innovations stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

LBT Innovations logo
LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.
Read More on LBT Innovations

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

857,080 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

10.81%

Beta

1.39

Who are the company insiders with the largest holdings of LBT Innovations?

LBT Innovations' top insider investors include:
  1. Brenton Barnes (Insider)
Learn More about top insider investors at LBT Innovations.